Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer

Danial Mehranfard1, Gabriela Perez2, Andres Rodriguez3

  • 1College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.

Abstract

Insights

This study reveals altered gene expression in colorectal cancer (CRC). Key genes in the renin-angiotensin system (RAS) are dysregulated, suggesting potential therapeutic targets for CRC treatment.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • The renin-angiotensin system (RAS) plays a role in various physiological processes.
  • Dysregulation of the RAS has been implicated in cancer development and progression.

Purpose of the Study:

  • To investigate the expression patterns of specific RAS-related genes in colorectal cancer (CRC).
  • To identify potential molecular mechanisms linking RAS to CRC oncogenicity.

Main Methods:

  • Quantitative gene expression analysis using chip arrays.
  • Statistical comparison of gene expression in normal versus cancerous tissues from the Gene Expression Omnibus (GEO) database.

Main Results:

  • Upregulation of angiotensinogen (AGT), aminopeptidase A (ENPEP), neprilysin (MME), and prolyl endopeptidase (PREP) in CRC specimens.
  • Downregulation of renin (REN), thimet oligopeptidase (THOP), neurolysin (NLN), prolyl carboxypeptidase (PRCP), aminopeptidase N (ANPEP), and Mas receptor (MAS1) in CRC specimens.

Conclusions:

  • Altered expression of RAS components suggests a potential role in CRC development.
  • Increased angiotensinogen and reduced metabolism may lead to angiotensinogen accumulation in CRC.
  • Downregulation of the ACE2/ANG 1-7/Mas axis may promote oncogenicity.
  • RAS components represent potential therapeutic targets for CRC treatment.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
34.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
606
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
946
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
203
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.9K